Rise In Incidence Of Cancer And Tumor Is Uplifting The Growth Of The Anastrozole Tablets Market
The growing prevalence of breast cancers around the globe is a prime factor propelling the growth of the anastrozole tablets market. According to the World Cancer Research Fund (WCRF) report of 2018, breast cancer is the most commonly occurring cancer in women and the second most common cancer globally. There were over 2 million new cases in 2018, globally. Furthermore, according to the World Health Organization (WHO) report of 2018, it is estimated that 627,000 women died from breast cancer in 2018, worldwide. On the other hand, frequent drug recalls are expected to hinder the growth of the anastrozole tablets market . For example, in May 2019, Zydus Pharmaceuticals USA Inc. announced that it voluntarily recalled multiple lots of anastrozole tablets (1mg) at the retail level. The product is under investigation by the U.S. FDA. The reason for drug recall was cross-contamination due to a GMP cleaning procedure failure in the fluid bed dry processor area during the manufacturing ...